| abstract |
The present invention is directed to a method of treating a lack of normal respiratory control, including the treatment of apnea and hypoventilation associated with sleep, obesity, certain drugs and other medical conditions. In one aspect, the invention provides impaired control of breathing by administering a composition comprising a combination of two or more compounds, wherein at least one of the compounds treats a lack of normal breathing. Opposed to treatment. In one aspect, the compound is an S-nitrosylation agent. |